278 related articles for article (PubMed ID: 30033361)
1. Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.
Gao P; Xia JH; Sipeky C; Dong XM; Zhang Q; Yang Y; Zhang P; Cruz SP; Zhang K; Zhu J; Lee HM; Suleman S; Giannareas N; Liu S; ; Tammela TLJ; Auvinen A; Wang X; Huang Q; Wang L; Manninen A; Vaarala MH; Wang L; Schleutker J; Wei GH
Cell; 2018 Jul; 174(3):576-589.e18. PubMed ID: 30033361
[TBL] [Abstract][Full Text] [Related]
2. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
Hua JT; Ahmed M; Guo H; Zhang Y; Chen S; Soares F; Lu J; Zhou S; Wang M; Li H; Larson NB; McDonnell SK; Patel PS; Liang Y; Yao CQ; van der Kwast T; Lupien M; Feng FY; Zoubeidi A; Tsao MS; Thibodeau SN; Boutros PC; He HH
Cell; 2018 Jul; 174(3):564-575.e18. PubMed ID: 30033362
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic regulatory circuits driven by 19q13 rs11672691 underlies prostate cancer aggressiveness.
Xia JH; Wei GH
Mol Cell Oncol; 2018; 5(6):e1516451. PubMed ID: 30525094
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB.
Bicak M; Wang X; Gao X; Xu X; Väänänen RM; Taimen P; Lilja H; Pettersson K; Klein RJ
Hum Mol Genet; 2020 Jun; 29(10):1581-1591. PubMed ID: 32065238
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
Jin HJ; Jung S; DebRoy AR; Davuluri RV
Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
[TBL] [Abstract][Full Text] [Related]
6. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
[TBL] [Abstract][Full Text] [Related]
7. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into genetic susceptibility to prostate cancer.
Tian P; Zhong M; Wei GH
Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
[TBL] [Abstract][Full Text] [Related]
9. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
10. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
[TBL] [Abstract][Full Text] [Related]
11. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants.
Spisák S; Lawrenson K; Fu Y; Csabai I; Cottman RT; Seo JH; Haiman C; Han Y; Lenci R; Li Q; Tisza V; Szállási Z; Herbert ZT; Chabot M; Pomerantz M; Solymosi N; ; Gayther SA; Joung JK; Freedman ML
Nat Med; 2015 Nov; 21(11):1357-63. PubMed ID: 26398868
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
13. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Väisänen MR; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei GH
Nat Genet; 2014 Feb; 46(2):126-35. PubMed ID: 24390282
[TBL] [Abstract][Full Text] [Related]
14. Association of six susceptibility Loci with prostate cancer in northern chinese men.
Zhang YR; Xu Y; Yang K; Liu M; Wei D; Zhang YG; Shi XH; Wang JY; Yang F; Wang X; Liang SY; Zhao CX; Wang F; Chen X; Sun L; Zhu XQ; Zhu L; Yang YG; Tang L; Jiao HY; Huo ZH; Yang Z
Asian Pac J Cancer Prev; 2012; 13(12):6273-6. PubMed ID: 23464444
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Amin Al Olama A; Kote-Jarai Z; Schumacher FR; Wiklund F; Berndt SI; Benlloch S; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Hunter DJ; Henderson BE; Thun MJ; Gaziano M; Giovannucci EL; Siddiq A; Travis RC; Cox DG; Canzian F; Riboli E; Key TJ; Andriole G; Albanes D; Hayes RB; Schleutker J; Auvinen A; Tammela TL; Weischer M; Stanford JL; Ostrander EA; Cybulski C; Lubinski J; Thibodeau SN; Schaid DJ; Sorensen KD; Batra J; Clements JA; Chambers S; Aitken J; Gardiner RA; Maier C; Vogel W; Dörk T; Brenner H; Habuchi T; Ingles S; John EM; Dickinson JL; Cannon-Albright L; Teixeira MR; Kaneva R; Zhang HW; Lu YJ; Park JY; Cooney KA; Muir KR; Leongamornlert DA; Saunders E; Tymrakiewicz M; Mahmud N; Guy M; Govindasami K; O'Brien LT; Wilkinson RA; Hall AL; Sawyer EJ; Dadaev T; Morrison J; Dearnaley DP; Horwich A; Huddart RA; Khoo VS; Parker CC; Van As N; Woodhouse CJ; Thompson A; Dudderidge T; Ogden C; Cooper CS; Lophatonanon A; Southey MC; Hopper JL; English D; Virtamo J; Le Marchand L; Campa D; Kaaks R; Lindstrom S; Diver WR; Gapstur S; Yeager M; Cox A; Stern MC; Corral R; Aly M; Isaacs W; Adolfsson J; Xu J; Zheng SL; Wahlfors T; Taari K; Kujala P; Klarskov P; Nordestgaard BG; Røder MA; Frikke-Schmidt R; Bojesen SE; FitzGerald LM; Kolb S; Kwon EM; Karyadi DM; Orntoft TF; Borre M; Rinckleb A; Luedeke M; Herkommer K; Meyer A; Serth J; Marthick JR; Patterson B; Wokolorczyk D; Spurdle A; Lose F; McDonnell SK; Joshi AD; Shahabi A; Pinto P; Santos J; Ray A; Sellers TA; Lin HY; Stephenson RA; Teerlink C; Muller H; Rothenbacher D; Tsuchiya N; Narita S; Cao GW; Slavov C; Mitev V; ; ; ; ; Chanock S; Gronberg H; Haiman CA; Kraft P; Easton DF; Eeles RA
Hum Mol Genet; 2013 Jan; 22(2):408-15. PubMed ID: 23065704
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
[TBL] [Abstract][Full Text] [Related]
17. 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.
Takata R; Takahashi A; Fujita M; Momozawa Y; Saunders EJ; Yamada H; Maejima K; Nakano K; Nishida Y; Hishida A; Matsuo K; Wakai K; Yamaji T; Sawada N; Iwasaki M; Tsugane S; Sasaki M; Shimizu A; Tanno K; Minegishi N; Suzuki K; Matsuda K; Kubo M; Inazawa J; Egawa S; Haiman CA; Ogawa O; Obara W; Kamatani Y; Akamatsu S; Nakagawa H
Nat Commun; 2019 Sep; 10(1):4422. PubMed ID: 31562322
[TBL] [Abstract][Full Text] [Related]
18. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk.
Jin G; Sun J; Isaacs SD; Wiley KE; Kim ST; Chu LW; Zhang Z; Zhao H; Zheng SL; Isaacs WB; Xu J
Carcinogenesis; 2011 Nov; 32(11):1655-9. PubMed ID: 21856995
[TBL] [Abstract][Full Text] [Related]
19. A 16q22.1 variant confers susceptibility to colorectal cancer as a distal regulator of ZFP90.
Yu CY; Han JX; Zhang J; Jiang P; Shen C; Guo F; Tang J; Yan T; Tian X; Zhu X; Ma D; Hu Y; Xie Y; Du W; Zhong M; Chen J; Liu Q; Sun D; Chen Y; Zou W; Hong J; Chen H; Fang JY
Oncogene; 2020 Feb; 39(6):1347-1360. PubMed ID: 31641208
[TBL] [Abstract][Full Text] [Related]
20. Two prostate cancer‑associated polymorphisms in the 3'UTR of IGF1R influences prostate cancer susceptibility by affecting miRNA binding.
Wang H; Huang W; Yu X; Li W; Huang Y; Mo Z; Gao Y; Zhou Q; Hu Y
Oncol Rep; 2019 Jan; 41(1):512-524. PubMed ID: 30365147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
